Updated: March 27, 2026
How to Help Your Patients Find Azasite in Stock: A Provider's Guide
Author
Peter Daggett

Summarize with AI
A provider's guide to helping patients find and access Azasite in 2026, including the EyeRx Direct program, workflow tips, and alternative prescribing strategies.
Helping Your Patients Access Azasite in 2026
When you prescribe Azasite (Azithromycin ophthalmic solution 1%) for bacterial conjunctivitis, you expect your patient to be able to pick it up at their pharmacy. But in 2026, that's often not what happens. Many patients call back frustrated, reporting that their pharmacy doesn't carry Azasite, can't order it, or has never heard of it.
This guide will help you understand the current availability landscape, give you practical steps to get Azasite into your patients' hands, and offer workflow tips to make the process smoother for your practice.
Understanding Current Azasite Availability
Azasite is not distributed through standard retail pharmacy wholesalers. Unlike most prescription eye drops, you can't send an Azasite prescription to CVS, Walgreens, or Walmart and expect it to be filled. The medication is available exclusively through the EyeRx Direct specialty pharmacy program.
This distribution model has been in place for some time, but many prescribers — especially those in primary care, urgent care, or emergency medicine — may not be aware of it. The result: patients receive prescriptions they can't fill, delaying treatment for an often-contagious infection.
Key availability facts:
- FDA reports product as "currently available" as of late 2025
- No formal shortage, but access limited to specialty distribution
- Increased demand due to erythromycin ophthalmic ointment shortage
- No generic available
Why Patients Can't Find Azasite
The most common reasons patients struggle to fill an Azasite prescription:
- Retail pharmacies don't stock it. Most chain and independent pharmacies cannot order Azasite through their standard wholesalers.
- Patients don't know about EyeRx Direct. Without being told about the specialty pharmacy program, patients have no way to access the product.
- Cost sticker shock. At $259–$300 retail (if somehow found), many patients abandon the prescription. They may not know about the $60 EyeRx Direct price.
- Insurance barriers. Many plans require prior authorization or step therapy, adding delays.
What Providers Can Do: 5 Steps
Step 1: Prescribe Through EyeRx Direct
The single most effective thing you can do is route the prescription directly to the EyeRx Direct specialty pharmacy program. Details:
- Website: azasite.com
- Patient cost: approximately $60 per 2.5 mL bottle
- Medication is shipped to the patient or a participating pharmacy
If your practice isn't set up with EyeRx Direct, consider establishing a relationship — it takes just one or two prescriptions to become familiar with the process.
Step 2: Educate Your Staff
Make sure front desk staff, medical assistants, and nurses know that Azasite requires the specialty pharmacy pathway. A brief note in your prescribing workflow or EHR can prevent the common mistake of sending the script to a retail pharmacy.
Step 3: Give Patients Clear Instructions
When prescribing Azasite, tell patients:
- "This medication is only available through a specialty pharmacy, not your regular pharmacy."
- "I'm sending the prescription to EyeRx Direct. You can also visit azasite.com for more information."
- "The cost through this program is about $60, which is much less than the retail price."
Step 4: Have a Backup Plan
If Azasite can't be accessed in a timely manner — or if cost is a barrier — have an alternative ready. For bacterial conjunctivitis, effective options include:
- Moxifloxacin 0.5% ophthalmic (generic Vigamox) — $15–$30
- Tobramycin 0.3% ophthalmic (generic Tobrex) — $10–$20
- Polymyxin B/Trimethoprim (generic Polytrim) — $10–$15
These generics are available at virtually every pharmacy and treat the same bacterial spectrum. For a detailed comparison, see: Alternatives to Azasite.
Step 5: Use Medfinder to Check Availability
Medfinder for Providers offers real-time pharmacy availability data. You or your staff can quickly check which pharmacies in your area have Azasite or alternatives in stock, helping you direct patients to the right location without trial and error.
Alternative Prescribing Strategies
Given Azasite's distribution complexity, consider these workflow approaches:
For Uncomplicated Bacterial Conjunctivitis
If a generic alternative is clinically appropriate, prescribing Moxifloxacin or Polytrim as first-line avoids the specialty pharmacy process entirely. Save Azasite for cases where you specifically want the macrolide mechanism, the convenient dosing schedule, or when a patient has allergies to fluoroquinolones or aminoglycosides.
For Patients Who Need Azasite Specifically
Route the prescription to EyeRx Direct and confirm the patient understands the process. For patients with insurance, consider obtaining prior authorization proactively if you anticipate coverage issues.
During the Erythromycin Shortage
If you're using Azasite as an erythromycin substitute for superficial ocular infections (per FDA/CDC guidance), be aware that demand is elevated. Having the EyeRx Direct pathway established will ensure you can access it when needed.
Workflow Tips for Your Practice
- Add a note to your EHR: When Azasite appears in the prescribing module, include a prompt that it requires EyeRx Direct
- Keep patient handouts: Print or email patients instructions for accessing azasite.com
- Track prior auth requirements: If your patient population frequently uses specific insurers, note which ones require PA for Azasite
- Consider cost conversations: Always mention the $60 EyeRx Direct price vs. $259–$300 retail — many patients assume their only option is the higher price
Final Thoughts
Azasite is an effective antibiotic eye drop with a convenient dosing schedule, but its specialty-only distribution requires providers to adjust their prescribing workflow. By routing prescriptions through EyeRx Direct, educating your staff and patients, and maintaining awareness of alternatives, you can ensure your patients get timely, affordable treatment for bacterial conjunctivitis.
For real-time availability data and provider tools, visit Medfinder for Providers. For clinical details on side effects and dosing, see: Azasite side effects: What to expect.
Frequently Asked Questions
Visit azasite.com for enrollment information. You can send prescriptions to the EyeRx Direct specialty pharmacy program electronically or by phone. Once set up, the process is straightforward — the medication is shipped to the patient or a participating pharmacy at approximately $60 per bottle.
For uncomplicated bacterial conjunctivitis, generic alternatives like moxifloxacin ($15–$30), tobramycin ($10–$20), or Polytrim ($10–$15) are clinically appropriate first-line options and far easier for patients to access. Reserve Azasite for cases where the macrolide class, convenient dosing, or specific coverage is needed.
If insurance denies coverage, direct the patient to the EyeRx Direct program where Azasite costs approximately $60 out of pocket. You can also file a prior authorization or appeal the denial. If cost remains prohibitive, switch to a generic alternative like Polytrim at $10–$15.
Yes. Medfinder for Providers at medfinder.com/providers offers real-time pharmacy availability data. You or your staff can quickly look up which pharmacies in your area have Azasite or alternative antibiotic eye drops in stock, saving time and improving the patient experience.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Ovide also looked for:
More about Ovide
32,326 have already found their meds with Medfinder.
Start your search today.





